Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ADOH (A Dose of Health) is a biotechnology and health technology company specializing in oral microbiome analysis and its implications for systemic health. The company offers a direct-to-consumer at-home testing kit that utilizes metagenomic sequencing to identify bacterial species in the mouth and assess their impact on oral and overall wellness. By providing personalized reports and actionable insights, ADOH aims to help individuals prevent oral diseases like periodontitis and understand the link between oral bacteria and chronic conditions such as cardiovascular disease and diabetes. Their platform integrates advanced sequencing technology with AI-driven analysis to deliver precise health data. ADOH is positioned at the intersection of dental care and preventive medicine, advocating for the importance of the oral-systemic connection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ADOH.